FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111608523> ?p ?o ?g. }

• W2111608523 endingPage "1632" @default.
• W2111608523 startingPage "1631" @default.
• W2111608523 abstract "The modern approach to lipid-lowering therapy is rooted in the event-driven, randomised clinical trial (RCT). From the Lipid Research Clinics Coronary Primary Prevention Trial to the Coronary Drug Project to the modern statin trials, guidelines have traditionally been informed by large RCTs driven by the outcomes that matter most—heart attacks and strokes.1 Based on a wealth of data from such RCTs, statins are now established as first-line drugs for nearly everyone considered to be at high risk of developing atherosclerotic cardiovascular disease (CVD).Unfortunately, in the current era, large event-driven RCTs have become increasingly hard to conduct.2 The incidence of CVD is declining in developed nations, requiring either very large sample sizes (a problem compounded by the well-documented decline in RCT participation) or a largely international trial population with limited generalisability. Given the known efficacy of statins, new lipid-lowering therapies must be tested as add-ons to statins, limiting their marginal efficacy and again necessitating larger sample sizes. The global economic slowdown has also limited non-pharmaceutical and pharmaceutical funding for large RCTs, particularly for existing therapies.The imaging-based surrogate endpoint trial was thought to be the solution to this problem.3 If one could document the benefit of a therapy on a highly sensitive atherosclerosis imaging endpoint, the theory states, one might need far fewer patients to prove the efficacy of a drug. While early statin surrogate endpoint studies showed plaque regression in close correlation with event reduction, studies of other drugs have failed to link surrogate endpoint changes to observed clinical benefits. One example was the ARBITER6-HALTS trial, which randomised patients to ezetimibe versus long-acting niacin as add-on therapy.4 This generally well-conducted trial of 363 patients was stopped early on the basis of a reduction in carotid intima-media thickness in the niacin arm. Although published in the …" @default.
• W2111608523 created "2016-06-24" @default.
• W2111608523 creator A5008531984 @default.
• W2111608523 creator A5036283255 @default.
• W2111608523 date "2013-09-16" @default.
• W2111608523 modified "2023-09-25" @default.
• W2111608523 title "Niacin—a case study for the role of event-driven versus surrogate endpoint trials" @default.
• W2111608523 cites W1496344240 @default.
• W2111608523 cites W1973355122 @default.
• W2111608523 cites W1980454378 @default.
• W2111608523 cites W2036034025 @default.
• W2111608523 cites W2040644547 @default.
• W2111608523 cites W2048246745 @default.
• W2111608523 cites W2048760408 @default.
• W2111608523 cites W2101969945 @default.
• W2111608523 cites W2109150493 @default.
• W2111608523 cites W2110533098 @default.
• W2111608523 cites W2118825330 @default.
• W2111608523 cites W2126666720 @default.
• W2111608523 cites W2156843987 @default.
• W2111608523 cites W2165605025 @default.
• W2111608523 cites W2186623609 @default.
• W2111608523 cites W2317000629 @default.
• W2111608523 doi "https://doi.org/10.1136/heartjnl-2013-304545" @default.
• W2111608523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24041650" @default.
• W2111608523 hasPublicationYear "2013" @default.
• W2111608523 type Work @default.
• W2111608523 sameAs 2111608523 @default.
• W2111608523 citedByCount "1" @default.
• W2111608523 countsByYear W21116085232014 @default.
• W2111608523 crossrefType "journal-article" @default.
• W2111608523 hasAuthorship W2111608523A5008531984 @default.
• W2111608523 hasAuthorship W2111608523A5036283255 @default.
• W2111608523 hasConcept C121332964 @default.
• W2111608523 hasConcept C126322002 @default.
• W2111608523 hasConcept C141341695 @default.
• W2111608523 hasConcept C177713679 @default.
• W2111608523 hasConcept C203092338 @default.
• W2111608523 hasConcept C2779662365 @default.
• W2111608523 hasConcept C2780092750 @default.
• W2111608523 hasConcept C2909914741 @default.
• W2111608523 hasConcept C3018127138 @default.
• W2111608523 hasConcept C500558357 @default.
• W2111608523 hasConcept C535046627 @default.
• W2111608523 hasConcept C62520636 @default.
• W2111608523 hasConcept C71924100 @default.
• W2111608523 hasConceptScore W2111608523C121332964 @default.
• W2111608523 hasConceptScore W2111608523C126322002 @default.
• W2111608523 hasConceptScore W2111608523C141341695 @default.
• W2111608523 hasConceptScore W2111608523C177713679 @default.
• W2111608523 hasConceptScore W2111608523C203092338 @default.
• W2111608523 hasConceptScore W2111608523C2779662365 @default.
• W2111608523 hasConceptScore W2111608523C2780092750 @default.
• W2111608523 hasConceptScore W2111608523C2909914741 @default.
• W2111608523 hasConceptScore W2111608523C3018127138 @default.
• W2111608523 hasConceptScore W2111608523C500558357 @default.
• W2111608523 hasConceptScore W2111608523C535046627 @default.
• W2111608523 hasConceptScore W2111608523C62520636 @default.
• W2111608523 hasConceptScore W2111608523C71924100 @default.
• W2111608523 hasIssue "22" @default.
• W2111608523 hasLocation W21116085231 @default.
• W2111608523 hasLocation W21116085232 @default.
• W2111608523 hasOpenAccess W2111608523 @default.
• W2111608523 hasPrimaryLocation W21116085231 @default.
• W2111608523 hasRelatedWork W1510385229 @default.
• W2111608523 hasRelatedWork W1852785632 @default.
• W2111608523 hasRelatedWork W2046855179 @default.
• W2111608523 hasRelatedWork W2169374891 @default.
• W2111608523 hasRelatedWork W2297790284 @default.
• W2111608523 hasRelatedWork W2738296161 @default.
• W2111608523 hasRelatedWork W3025555446 @default.
• W2111608523 hasRelatedWork W3080304190 @default.
• W2111608523 hasRelatedWork W3157645496 @default.
• W2111608523 hasRelatedWork W3205017884 @default.
• W2111608523 hasVolume "99" @default.
• W2111608523 isParatext "false" @default.
• W2111608523 isRetracted "false" @default.
• W2111608523 magId "2111608523" @default.
• W2111608523 workType "article" @default.